Skip to main content

Table 3 Demographics of survey respondents

From: Correction to: A Global Survey of Disease Burden in Patients Who Carry a Diagnosis of Chronic Inflammatory Demyelinating Polyneuropathy

  Global, likely CIDP (n = 222) Global, somewhat likely CIDP (n = 204) Global, unlikely CIDP (n = 169)
Sex, male, % 46 39 51
Age (at diagnosis), n (%)
 ≤ 29 15 (6.76) 16 (7.84) 9 (5.33)
 30–39 32 (14.41) 35 (17.16) 19 (11.24)
 40–49 46 (20.72) 50 (24.51) 30 (17.75)
 50–59 69 (31.01) 63 (30.88) 49 (28.99)
 60–69 47 (21.17) 29 (14.22) 41 (24.26)
 70–79 12 (5.41)* 10 (4.9) 20 (11.83)*
 ≥ 80 1 (0.45) 1 (0.49) 1 (0.59)
Employment status (at diagnosis), %
 Employed 71 68 59
  Paid full-time 61 63 51
  Paid part-time 10 5 8
 Retired 11 7 20
 Student 2 3 2
 On disability 6 10 8
 Unemployed 5 4 5
 Other/unpaid work 5 7 6
Current treatment at survey completion, %
 IVIg 61 61 59
 SCIg 2 3 2
 Corticosteroids 23 22 15
 IVIg and steroids 12 14 9
 Other immunosuppressive drugs 15 17 18
 Plasma exchange 3 2 2
  1. IVIg intravenous immunoglobulin, SCIg subcutaneous immunoglobulin
  2. *Statistically significantly different determined by 95% confidence intervals and z tests